Document is current
Any future updates will be listed below
-
Authors
Arciero, Julia https://orcid.org/0000-0002-2882-3653
Fry, Brendan C.
Gyurek, Croix
Albright, Amanda
Eckert, George
Antman, Gal
Verticchio, Alice
Siesky, Brent
Harris, Alon
-
Funding
Funding for this research was provided by:
National Science Foundation (DMS-1654019, DMS-2150108)
New York Eye and Ear Infirmary of Mount Sinai
Research to Prevent Blindness
Foundation for the National Institutes of Health (NIH R01EY030851, NIH R01EY034718)
Glaucoma Foundation
- License Information
-
More Information
Article History
Received: 26 March 2024
Revised: 7 April 2025
Accepted: 20 May 2025
First Online: 5 June 2025
Declarations
:
: There are no conflicts of interest. Alon Harris would like to disclose that he received remuneration from AdOM, Qlaris, and Cipla for serving as a consultant, and he serves on the board of AdOM, Qlaris and SlitLed. Alon Harris holds an ownership interest in AdOM, Oxymap, Qlaris, and SlitLed. Alice Verticchio Vercellin is an external collaborator of the IRCCS Fondazione Bietti, Rome. If you have questions regarding paid relationships that your physician/researcher may have with industry, you are encouraged to talk with your physician/researcher, or check for industry relationships posted on individual faculty pages on our website at .
